| NVP-BEZ235 |
ENSG00000104691.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000124835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000124915.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000146666.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000149656.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000157306.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000170161.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000175773.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000176728.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000177337.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000177410.8 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000177738.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000177757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000178947.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000179141.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000179406.6 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000180422.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000181097.5 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000181798.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000182109.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000182873.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000183242.7 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000183535.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000185433.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000185904.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000186019.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000188185.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000189149.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000196421.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000196553.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000196696.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000197210.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000197308.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000197934.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000197989.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000198106.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000198221.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000203288.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000203499.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000203801.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000203801.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000203808.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000203875.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000204011.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000204055.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000204362.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000204603.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000204791.4 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000204832.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000204837.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000204837.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000204934.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000205037.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000205037.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000205488.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000205913.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000205913.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000206028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000206195.6 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000206337.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000212694.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000213904.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000214145.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000214650.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000214725.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000214851.4 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000214851.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000214894.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000214922.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000215068.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000215241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000215417.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000215447.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000215859.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000215863.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000217576.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000221571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000222041.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223396.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000223401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223404.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223528.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000223685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223711.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223749.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223759.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223768.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000223774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223779.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223804.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223881.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223884.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223901.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224032.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224032.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224081.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224086.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000224087.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000224222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000224269.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224356.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000224376.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000224460.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224505.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224536.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000224635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000224691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224729.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000224799.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000224804.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000224848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000224883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224888.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000224897.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224905.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000224959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000224972.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000224973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000224992.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225032.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000225032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225156.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225163.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000225180.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000225205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225210.5 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000225218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000225265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225278.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000225292.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000225335.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225439.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000225439.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000225465.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225484.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000225548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000225643.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000225684.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000225721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000225744.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225761.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225783.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000225914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000225914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000225938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000225963.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226067.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226291.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226312.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000226330.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226367.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000226377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226386.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000226419.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000226419.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000226419.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226471.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226505.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000226508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226562.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000226574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000226581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226627.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226637.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000226674.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226688.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226738.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226833.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000226889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000226900.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000226935.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000226944.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227071.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000227094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000227155.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000227188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227210.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000227210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227215.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227253.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227256.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227256.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227372.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227527.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000227533.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000227619.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227673.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227695.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227706.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000227896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227908.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000227959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228060.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228079.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228106.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000228274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228318.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000228350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228414.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228540.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228629.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000228649.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000228661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228709.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000228719.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000228737.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228775.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228839.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228878.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000228886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000228889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000228889.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000228933.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000228962.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229127.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000229152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229152.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000229154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229192.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000229228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000229294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000229368.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000229368.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000229407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229645.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229646.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229694.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229776.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000229839.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000229847.4 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000229867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000229869.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000229941.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000229955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000229996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000230010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000230024.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000230090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000230131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000230176.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230212.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000230289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230303.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230368.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000230489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000230498.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000230499.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000230552.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230612.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230641.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230735.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230773.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230812.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000230850.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000230912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230925.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000231023.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231054.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000231081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000231156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000231160.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231201.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231217.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231324.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231486.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000231486.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000231519.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231519.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000231530.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231535.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000231551.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231607.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231638.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000231652.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000231721.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000231728.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000231734.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000231734.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231760.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000231856.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231856.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231871.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231944.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000231948.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000231993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232065.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000232082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000232098.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000232118.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232139.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232151.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000232194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232295.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232295.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232324.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232386.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232623.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000232638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232693.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232719.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232721.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232729.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000232762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000232814.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000232987.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000233033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000233101.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233117.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000233184.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000233251.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000233255.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000233368.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233411.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233429.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000233559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233611.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233621.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000233672.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000233672.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233757.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000233776.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233806.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000233817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000233844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000233845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000233901.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000233937.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234147.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000234181.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000234215.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234292.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234311.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234449.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234503.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234608.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000234678.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000234705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234773.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234817.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234817.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234883.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234899.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000234899.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000234902.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000234936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000234943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000234996.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000234997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235049.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000235052.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000235066.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000235070.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000235072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000235079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000235091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235106.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000235106.4 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000235117.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000235180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000235204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000235246.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235257.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235257.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000235314.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235501.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235527.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000235545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235560.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235590.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000235641.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235652.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235760.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000235779.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000235781.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235781.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235795.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235872.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000235999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000235999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236016.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000236095.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236199.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236242.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236256.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236283.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000236384.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000236427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000236438.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000236514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000236519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000236537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236617.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000236703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000236810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236824.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236824.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000236908.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000236914.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000236924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000236935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000236943.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000237017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000237149.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237200.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000237232.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237250.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000237292.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000237343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000237410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237491.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237512.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237588.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000237697.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000237714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000237737.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000237738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000237786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000237807.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237852.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000237857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237877.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237940.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000237945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000237976.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000238035.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000238045.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000238078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000238107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000238123.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000238133.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000238260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000238261.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000238273.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000238358.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000238755.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000239002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000239335.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000239415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000239445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000239498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000239653.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000239705.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000240032.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000240137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000240207.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000240350.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000240710.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000240875.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000241125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000241135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000241135.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000241155.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000241155.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000241359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000241770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000241818.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000241912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000242078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000242082.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000242357.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000242641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000242753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000242759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000242902.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000242925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000243008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000243055.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000243176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000243176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000243230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000243319.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243415.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000243479.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000243533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243629.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000243819.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000243836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243902.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000243926.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000244327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244383.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244513.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000244586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000244998.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245059.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000245105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000245112.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245164.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000245164.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000245311.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245468.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245479.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245526.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000245532.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000245571.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245614.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000245648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000245711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000245748.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000245857.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000245975.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000246130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000246225.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000246228.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000246250.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000246273.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000246323.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000246379.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000246523.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000246523.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000246526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000246640.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000246792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000246863.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000246898.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000246985.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000247092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247213.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247228.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000247373.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000247400.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247400.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000247400.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247498.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247556.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247708.3 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000247809.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000247853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000247877.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000247970.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000248115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000248161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000248161.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000248175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000248275.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248360.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000248360.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000248367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000248445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248544.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000248587.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000248890.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000249001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000249169.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000249241.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249348.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000249348.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000249412.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000249532.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000249637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249673.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000249678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000249706.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000249771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000249787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000249885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000249896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250033.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000250039.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250116.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000250159.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250220.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000250295.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000250326.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000250337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250415.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000250451.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250548.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250616.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250643.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000250659.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250770.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000250786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000250893.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250910.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000250990.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000250999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251003.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251034.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251034.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000251129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251136.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251161.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000251179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000251194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251292.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000251323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000251364.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000251379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000251405.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000251455.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251555.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000251556.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000251586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000251603.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251623.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000251666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253125.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000253154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000253210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253217.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000253270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253307.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253352.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253390.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000253390.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253392.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253392.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253399.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253406.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253438.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000253438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253515.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000253552.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253567.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000253696.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000253878.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000253944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000253948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254031.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254153.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000254187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254197.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000254266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000254281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254286.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000254290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254389.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254560.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254639.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254682.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000254812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000254833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254842.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000254859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000254900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000254910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254967.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000254981.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255050.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000255165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255236.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000255299.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255337.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255362.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000255409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000255410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000255443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000255487.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255507.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000255507.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255568.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000255621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000255672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255843.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000255893.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000255970.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000256006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256050.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256116.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000256116.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000256155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000256299.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000256427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000256458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000256481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000256576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256705.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000256746.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000256973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000257038.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000257052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000257241.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000257258.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000257261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000257346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257381.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257391.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000257438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257475.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000257488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000257527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000257563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000257605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000257613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000257636.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000257654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000257696.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000257718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000257759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000257829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000257831.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000257877.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000257900.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258199.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258260.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000258343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258378.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000258413.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000258428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258450.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258450.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258451.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000258454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000258457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000258521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258649.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258725.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000258736.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258813.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258819.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000258844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000258946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258957.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000258959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000259017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259062.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000259091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000259146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259215.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259251.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000259275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259287.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259319.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000259327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259341.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259349.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000259370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259408.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000259408.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259417.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259417.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000259418.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000259424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259542.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259584.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000259617.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259654.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259656.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259663.2 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000259682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259712.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259727.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259732.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000259758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259782.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000259942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000259943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260011.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260088.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260177.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260193.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260279.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260328.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260329.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260369.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260436.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260448.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000260517.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260517.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260579.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260593.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260619.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000260805.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260830.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000260831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000260871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000260877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260877.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000260955.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000260986.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000260992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261024.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261126.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261126.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000261159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000261183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261231.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261267.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261288.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261326.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261326.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261360.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261372.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261420.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261431.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261437.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261438.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261441.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261469.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261471.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261490.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000261574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261589.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261613.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261630.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000261654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261654.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261731.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261754.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261766.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261780.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000261786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261827.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000261879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000261888.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000261924.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000262119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262339.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000262380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000262580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000262580.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000262663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262678.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000262686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000262721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000262721.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000262823.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000262877.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000262879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000262973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000263272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263316.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000263338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263412.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000263466.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263674.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000263766.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000263847.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000263862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000263874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000263893.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000264112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000264207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264269.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000264339.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264735.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000264885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000264895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000264937.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000265055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000265218.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000265349.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000265496.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000265799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000265992.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000266010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266088.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266120.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266126.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000266304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266313.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000266385.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000266469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000266473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000266473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000266473.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266538.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000266541.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266541.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000266651.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000266783.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266821.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000266913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000266918.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000266927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000266930.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266942.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000266970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266976.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000266976.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000266983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000266987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000266999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267003.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267040.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267069.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267073.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000267141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267149.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267166.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267197.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000267201.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267221.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267246.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267287.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267304.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267395.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000267405.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000267439.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267446.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000267504.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267506.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000267522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000267529.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000267530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267546.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267582.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267729.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267747.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267765.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000267767.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000267924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000268001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000268186.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268340.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000268530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000268536.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268543.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000268544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000268583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000268670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000268683.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269054.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000269148.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000269191.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269202.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269480.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269483.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000269486.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269560.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000269574.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000269609.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000269814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000269825.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269911.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269923.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000269972.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269974.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270000.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000270009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000270010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270041.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000270137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000270165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270184.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000270419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270681.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000270988.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271009.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271147.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271147.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271259.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000271270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271335.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271387.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000271551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271554.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000271590.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271709.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000271781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000271782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000271833.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000271869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000271888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271888.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271911.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271911.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271967.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000271992.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000271996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272068.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000272081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272087.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272092.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272097.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272148.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272198.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000272211.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272211.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272361.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272368.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272379.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272440.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272516.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272622.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000272630.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272630.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272662.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272668.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272702.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000272707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272721.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272796.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272871.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000272913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272915.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272953.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000272979.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000272983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000273000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273007.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| NVP-BEZ235 |
ENSG00000273008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000273061.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273076.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273139.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000273142.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000273143.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| NVP-BEZ235 |
ENSG00000273218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000273232.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000273249.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273257.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000273305.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273305.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273329.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000273342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273355.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000273366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273374.1 |
Predicted lncRNA |
Esophageal cancer |
|
| NVP-BEZ235 |
ENSG00000273384.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| NVP-BEZ235 |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| NVP-BEZ235 |
ENSG00000273424.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273464.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| NVP-BEZ235 |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| NVP-BEZ235 |
ENSG00000273473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
ENSG00000273483.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| NVP-BEZ235 |
NCYM |
Curated lncRNA |
neuroblastoma |
|
